Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Auto-HSCT with haploidentical G-CSF–mobilized PBMC infusion in hematologic malignancies
ChiCTR-IIR-16008212Phase 2Suspended
- Sponsor
- Xinqiao Hospital
- Start
- Apr 2016
- Modality
- Cell Therapies
- Countries
- 1
01
Overview
Phase 2, randomised trial of granulocyte colony-stimulating factor-mobilized peripheral blood mononuclear cells in hematopoietic malignancies (2 arms), sponsored by Xinqiao Hospital. Primary endpoint: Overall survival. Started Apr 2016; status: suspended.
02
Drugs
granulocyte colony-stimulating factor-mobilized peripheral blood mononuclear cells
03
Conditions
hematopoietic malignancies
Beyond the preview
Go deeper on ChiCTR-IIR-16008212.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-IIR-16008212.